No Data
No Data
William Blair Reaffirms Their Buy Rating on ARS Pharmaceuticals (SPRY)
Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (SPRY) and Stryker (SYK)
ARS Pharmaceuticals Air Lease ALK-Abello
Express News | ARS Pharmaceuticals Inc - Pharma Received $145 Million Upfront From Alk
ARS Pharmaceuticals Announces Co-Promotion Agreement With Partner and Global Allergy Leader ALK-Abelló A/S to Expand Reach of Neffy (Epinephrine Nasal Spray) to Additional U.S. Pediatricians
Express News | ARS Pharmaceuticals Announces Co-Promotion Agreement With Partner and Global Allergy Leader Alk-Abelló A/S to Expand Reach of Neffy® (Epinephrine Nasal Spray) to Additional U.S. Pediatricians